Sarah Poplin, CNM
Advanced Practice Midwife · Tulsa, OKNPI 1497830046
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 33.1% of the total. Reporting peaked in 2021 at $620 and has fallen 87.1% since, to $80 in 2025. Among advanced practice midwife clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $14.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$589
- Lilly USA, LLC$160
- Merck$155
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$121
- Novo Nordisk$108
- Mayne Pharma Commercial LLC$94
- plus $551 from 13 others
What the payments were for
- Food & beverage$1,778100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $589 |
| Lilly USA, LLC | 11 | $160 |
| Merck | 11 | $155 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $121 |
| Novo Nordisk | 6 | $108 |
| Mayne Pharma Commercial LLC | 7 | $94 |
| Bayer | 5 | $87 |
| Astellas Pharma US Inc | 5 | $81 |
| Organon | 8 | $80 |
| AstraZeneca | 4 | $56 |
| Amgen | 3 | $44 |
| Lundbeck LLC | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Biogen | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $13 |
How this compares
$1,778 in reported general payments places this provider in the 95th percentile of 35 advanced practice midwife providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $1,386 |
| ProgesteroneProgesterone, Micronized | 14 | $639 |
Paid to pharmacies, not to this prescriber.
Other advanced practice midwife in Tulsa
- Shaun BaranowskiTulsa$2K
- Jessica CottonTulsa$350
- Diane DayTulsa$294
- Kimberely KmitaTulsa$247
- Bethany GarciaTulsa$192
- Kathleen BurrTulsa$17
- Sarah TrostStillwater$1K
- Amy EmersonJenks$246
- Sarah NobleBroken Arrow$245
- Shana SolisOklahoma City$240
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.